How a CRISPR Sickle Cell Therapy Moved From Lab to Clinical Trial
· newswise.com · popularity 20/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at newswise.com →
Summary
<img src="https://www.newswise.com/legacy/image.php?image=https://media.newswise.com/pio/articles/857671/6ae3c95be4f9c_Zulema_RG_Sickle_Cell_Feature_Image_857671.png&width=100&height=150" alt="Newswise image" />A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 4.